Skip to main
PEPG

PepGen Inc (PEPG) Stock Forecast & Price Target

PepGen Inc (PEPG) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 60%
Buy 40%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PepGen Inc. is advancing its Enhanced Delivery Oligonucleotide platform, targeting severe neuromuscular and neurologic diseases, which positions the company favorably within the biotechnology sector. The clinical data provided indicates a substantial variability in splicing correction improvement, with indications that a well-performing candidate could significantly impact market perception and valuation should it achieve a mean bi-allelic correction greater than 25% with a clean safety profile. Furthermore, the company’s innovative approach to improving tissue penetration and cellular uptake enhances its potential for successful therapeutic outcomes, thereby bolstering optimism about its future financial performance.

Bears say

PepGen Inc faces significant challenges that contribute to a negative outlook on its stock, primarily related to potential safety concerns associated with its Enhanced Delivery Oligonucleotide platform. The efficacy of PGN-EDODM1 may fall short of expectations based on preclinical data, and existing regulatory pathways for related therapeutics are not well defined, which could extend the approval timeline. Additionally, the risk of negative headlines concerning DMPK-targeting technology, unrelated to PepGen, could adversely affect investor sentiment and stock performance.

PepGen Inc (PEPG) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 60% of analysts recommend a Strong Buy, 40% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PepGen Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PepGen Inc (PEPG) Forecast

Analysts have given PepGen Inc (PEPG) a Strong Buy based on their latest research and market trends.

According to 5 analysts, PepGen Inc (PEPG) has a Strong Buy consensus rating as of Apr 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $11.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $11.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PepGen Inc (PEPG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.